Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00528398 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: idarubicin

Sponsor

City of Hope Medical Center

Collaborators

[object Object]